Neuphoria Therapeutics Inc. · NASDAQ:NEUP
Baselake Partners, LP's stake in Neuphoria Therapeutics Inc. fell to 4.10% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 6, 2026
Baselake Partners, LP's stake in Neuphoria Therapeutics Inc. fell to 4.10%, 222,222 shares, as a passive investor on Dec 31, 2025. Filed Feb 6, 2026 (Schedule 13G/A).
- Stake
- 4.10%
- Shares
- 222,222
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baselake Partners, LP | 4.10% | 222,222 |
| Baselake Management, LLC | 4.10% | 222,222 |
| David Paolella | 4.10% | 222,222 |
Source
Related
- Neuphoria Therapeutics Inc.
- Baselake Partners, LP
- Neuphoria Therapeutics Inc. shareholders
- Schedule 13G · Baselake Partners, LP · Oct 31, 2025
- Schedule 13G · AdvisorShares Trust · Oct 5, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 28, 2026
- Schedule 13D/A · Lynx1 Capital Management LP · Dec 29, 2025
- Schedule 13D/A · Lynx1 Capital Management LP · Dec 2, 2025
- Schedule 13D/A · Lynx1 Capital Management LP · Nov 28, 2025